National Comorbidity Survey

National Comorbidity Survey
Name	National Comorbidity Survey
Country	United States
Funding	National Institute of Mental Health
Period	1990–1992 (baseline)
Sample size	~8,098
Topics	Mental disorders, epidemiology, comorbidity

National Comorbidity Survey The National Comorbidity Survey was a landmark epidemiological study of mental disorders in the United States conducted in 1990–1992 that estimated prevalence, correlates, and comorbidity of psychiatric conditions. Led by investigators affiliated with the National Institute of Mental Health, Harvard University, and the University of Michigan, the survey produced influential data used by policymakers, clinicians, and researchers across institutions such as the Centers for Disease Control and Prevention, World Health Organization, and American Psychiatric Association. The dataset informed revisions of diagnostic practices and spurred subsequent population studies including collaborations with the Substance Abuse and Mental Health Services Administration.

Overview

The survey assessed psychiatric disorders using structured interviews administered to a nationally representative sample of civilians aged 15–54, generating lifetime and 12‑month prevalence estimates tied to demographic variables associated with institutions like the U.S. Census Bureau and analytic standards cited by the Institute of Medicine (United States). Findings were reported in peer‑reviewed outlets affiliated with publishers such as Oxford University Press and Cambridge University Press and presented at conferences hosted by the American Public Health Association and the Society for Epidemiologic Research. The project connected to broader initiatives led by the National Academy of Sciences and influenced public health programs under the U.S. Department of Health and Human Services.

History and Development

Development began in the late 1980s under the auspices of the National Institute of Mental Health with principal investigators who had ties to Columbia University, Yale University, and the University of California, Los Angeles. The design drew on earlier psychiatric epidemiology projects from the Epidemiologic Catchment Area program and methods promoted by the World Health Organization's psychiatric research units. Funding and oversight involved stakeholders including the Robert Wood Johnson Foundation and advisory panels convened at venues such as the Institute of Medicine (United States). Fieldwork contractors included survey firms with experience working for the Bureau of Labor Statistics and the National Center for Health Statistics.

Methodology

The survey used the Composite International Diagnostic Interview methodology adapted from instruments developed through collaborations with the World Health Organization and research groups at Harvard University and Johns Hopkins University. Interviewers were trained to implement diagnostic algorithms consistent with criteria in the Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised and consultations with contributors from Columbia University and University of Pennsylvania. Sampling frames relied on procedures allied with the U.S. Census Bureau and weighting strategies similar to those used by the Behavioral Risk Factor Surveillance System. Data management and statistical analyses were performed using systems and software linked to research at Carnegie Mellon University and computing resources parallel to those at Lawrence Berkeley National Laboratory.

Key Findings

Key results documented high lifetime prevalence for mood disorders, anxiety disorders, and substance use disorders, with pervasive comorbidity patterns echoed in literature from American Psychiatric Association, Royal College of Psychiatrists, and translational work at Massachusetts General Hospital. The survey identified demographic correlates involving age cohorts tracked by the U.S. Census Bureau and socioeconomic indicators examined by the Brookings Institution and Urban Institute. Findings were cited in policy debates at the White House and program planning at agencies including the Substance Abuse and Mental Health Services Administration and informed clinical guideline development discussed at the National Institutes of Health consensus conferences.

Subsequent Waves and Related Studies

Follow‑up projects included a nationally representative replication, the National Comorbidity Survey Replication carried out in the early 2000s with collaborators from Harvard Medical School, Yale School of Medicine, and the University of Michigan. Internationally comparable surveys were launched collaborating with the World Health Organization World Mental Health Survey Initiative and research centers such as the London School of Hygiene & Tropical Medicine and University College London. The dataset enabled linkage studies with cohorts maintained by institutions like Johns Hopkins University and spurred specialty studies funded by the Robert Wood Johnson Foundation and analyzed at the Kaiser Permanente research divisions.

Impact and Influence

The survey shaped epidemiological standards used by agencies including the Centers for Disease Control and Prevention, influenced diagnostic research at the American Psychiatric Association, and underpinned mental health policy discussions in forums such as the National Academy of Medicine. Academic outputs appeared in journals associated with institutions like Oxford University Press and Cambridge University Press and informed training programs at schools including Columbia University Mailman School of Public Health and Harvard T.H. Chan School of Public Health. Its models for measuring comorbidity influenced research at specialty centers such as Massachusetts General Hospital and Mayo Clinic.

Criticisms and Limitations

Critiques addressed sampling age limits compared with surveys by the National Center for Health Statistics and questioned diagnostic algorithms relative to later revisions of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition and criteria discussed at American Psychiatric Association conferences. Methodological limitations were debated in methodological panels convened at the Institute of Medicine (United States) and in commentaries from investigators at Yale University, Columbia University, and University of California, Los Angeles. Concerns included reliance on self‑report, response bias documented in comparative work funded by the Robert Wood Johnson Foundation, and challenges of cross‑study comparability raised by the World Health Organization World Mental Health collaborators.

Category:Epidemiological studies